Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36655 clinical trials
Therapeutic Recommendations for Nephroblastoma

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

wilms' tumour / nephroblastoma
  • 0 views
  • 19 Feb, 2024
Cardio-Oncology Registry

CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.

cardiotoxicity
cancer
  • 0 views
  • 19 Feb, 2024
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection.

hereditary cancer syndromes
blood test
hereditary cancer
cell-free dna
cancer
  • 0 views
  • 19 Feb, 2024
Duke Spine Outcome Study (DSOS)

The study will require obtaining spinal lesions (tumor, etc.), blood, and bone marrow samples (from non-lesional bone) from selected patients, which will be collected during your surgery.

metastasis
spinal disease
spinal diseases
metastatic disease
spine surgery
  • 0 views
  • 19 Feb, 2024
Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

P patients with acute obstructive colon cancer I resection or bridge to surgery with stent or stoma C emergency procedure O morbidity and mortality within 30 days, 90 day mortality and 3 & 5 years overall survival

metastasis
colon cancer
colon resection
colon operation
obstruction
  • 0 views
  • 19 Feb, 2024
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Nucleix EpiCheck tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification …

cancer
cfdna
  • 0 views
  • 19 Feb, 2024
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA test results and may be recommended for adjuvant chemotherapy or …

colorectal cancer
adenocarcinoma
adenocarcinoma of colon
adenocarcinoma of the colon
adjuvant
  • 0 views
  • 19 Feb, 2024
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of …

intraductal papillary mucinous neoplasms of the pancreas
endoscopy
pancreatitis
ipmn
cancer
  • 0 views
  • 19 Feb, 2024
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Study to gather information about the optimal placement of Ra-223 in the order of different treatments in terms of the effect on patients and in terms of the use of healthcare services for the treatment of Canadian patients with prostate gland cancer which spread to other parts of the body. …

  • 0 views
  • 19 Feb, 2024
A Study of miRNA 371 in Patients With Germ Cell Tumors

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

human chorionic gonadotropin
lactate dehydrogenase
ribonucleic acid
orchiectomy
alpha fetoprotein
  • 0 views
  • 19 Feb, 2024